Drug: GLEEVEC Injury: Peripheral swelling Quarter: 2016Q3
Total Records: 18 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 112226937 | GLEEVEC | Peripheral swelling | NOVARTIS | 72.03 YR | M | 0 | 20160817 | CA |
| 123883823 | GLEEVEC | Peripheral swelling | NOVARTIS | 66.89 YR | F | 0 | 20160921 | COUNTRY NOT SPECIFIED |
| 125492051 | GLEEVEC | Peripheral swelling | NOVARTIS | 54.09 YR | F | 0 | 20160712 | US |
| 125711271 | GLEEVEC | Peripheral swelling | BAUSCH AND LOMB | 0.00 | F | 0 | 20160719 | US |
| 125727352 | GLEEVEC | Peripheral swelling | NOVARTIS | 63.10 YR | F | 0 | 20160725 | US |
| 125814132 | GLEEVEC | Peripheral swelling | NOVARTIS | 86.61 YR | F | 66 KG | 20160919 | COUNTRY NOT SPECIFIED |
| 125846801 | GLEEVEC | Peripheral swelling | NOVARTIS | 0.00 | F | 0 | 20160722 | COUNTRY NOT SPECIFIED |
| 125859051 | GLEEVEC | Peripheral swelling | 0.00 | M | 180 LBS | 20160722 | US | |
| 126510951 | GLEEVEC | Peripheral swelling | 64.00 YR | M | 0 | 20160812 | US | |
| 126759131 | GLEEVEC | Peripheral swelling | NOVARTIS | 73.65 YR | 0 | 20160823 | COUNTRY NOT SPECIFIED | |
| 127010121 | GLEEVEC | Peripheral swelling | NOVARTIS | 0.00 | M | 0 | 20160831 | COUNTRY NOT SPECIFIED |
| 127419951 | GLEEVEC | Peripheral swelling | NOVARTIS | 0.00 | F | 0 | 20160914 | US |
| 127670651 | GLEEVEC | Peripheral swelling | NOVARTIS | 0.00 | F | 0 | 20160921 | US |
| 127975051 | GLEEVEC | Peripheral swelling | FDA-CTU | 0.00 | M | 200 LBS | 20160929 | US |
| 127981951 | GLEEVEC | Peripheral swelling | NOVARTIS | 0.00 | M | 0 | 20160930 | US |
| 127986671 | GLEEVEC | Peripheral swelling | NOVARTIS | 80.04 YR | M | 0 | 20160930 | US |
| 900241423 | GLEEVEC | Peripheral swelling | SANDOZ | 67.76 YR | M | 0 | 20160923 | COUNTRY NOT SPECIFIED |
| 946364016 | GLEEVEC | Peripheral swelling | NOVARTIS | 64.22 YR | M | 0 | 20160714 | COUNTRY NOT SPECIFIED |
Total Records: 18 Number of Pages: 1